FDA OKs Merck drug that prevents infection post-stem cell transplant

(Reuters) - Merck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday.